{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:19:23Z","timestamp":1788016763746,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T00:00:00Z","timestamp":1329350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00540-012-1347-0","type":"journal-article","created":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T10:58:10Z","timestamp":1329303490000},"page":"579-584","source":"Crossref","is-referenced-by-count":9,"title":["Calcium channel blockers are inadequate for malignant hyperthermia crisis"],"prefix":"10.1007","volume":"26","author":[{"given":"Takako","family":"Migita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Mukaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"key":"1347_CR1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/bja\/85.1.118","volume":"85","author":"PM Hopkins","year":"2000","unstructured":"Hopkins PM. Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth. 2000;85:118\u201328.","journal-title":"Br J Anaesth"},{"key":"1347_CR2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2217\/14622416.9.11.1657","volume":"9","author":"KM Stowell","year":"2008","unstructured":"Stowell KM. Malignant hyperthermia: a pharmacogenetic disorder. Pharmacogenomics. 2008;9:1657\u201372.","journal-title":"Pharmacogenomics."},{"key":"1347_CR3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010;110:498\u2013507.","journal-title":"Anesth Analg"},{"key":"1347_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rares Dis. 2007;2:21\u201334.","journal-title":"Orphanet J Rares Dis"},{"key":"1347_CR5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1213\/00000539-198405000-00001","volume":"63","author":"LS Saltzman","year":"1984","unstructured":"Saltzman LS, Kates RA, Corke BC, Norfleet EA, Heath KR. Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine. Anesth Analg. 1984;63:473\u20138.","journal-title":"Anesth Analg"},{"key":"1347_CR6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000542-198609001-00250","volume":"65","author":"C Lynch 3rd","year":"1986","unstructured":"Lynch C 3rd, Durbin CG Jr, Fisher NA, Veselis RA, Althaus JS. Effects of dantrolene and verapamil on atrioventricular condition and cardiovascular performance in dogs. Anesth Analg. 1986;65:252\u20138.","journal-title":"Anesth Analg"},{"key":"1347_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF03015958","volume":"43","author":"M Freysz","year":"1996","unstructured":"Freysz M, Timour Q, Bemaud C, Bertrix L, Faucon G. Cardiac implications of amlodipine-dantrolene combinations. Can J Anaesth. 1996;43:50\u20135.","journal-title":"Can J Anaesth"},{"key":"1347_CR8","doi-asserted-by":"crossref","unstructured":"Glahn KP, Ellis FR, Halsall PJ, Muller CR, Snoeck MMJ, Urwyler A, Wappler F; European Malignant Hyperthermia Group. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anasth. 2010;105:417\u201320.","DOI":"10.1093\/bja\/aeq243"},{"key":"1347_CR9","doi-asserted-by":"crossref","unstructured":"Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert, GA, Kaplan RF, Muldoon SM, Nelson T E, Ording H, Rosenberg H, Waud BE, Wedel DJ. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994;80:771\u20139.","DOI":"10.1097\/00000542-199404000-00008"},{"key":"1347_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0076-6879(88)57064-7","volume":"157","author":"M Endo","year":"1988","unstructured":"Endo M, Iino M. Measurement of Ca release in skinned fibers from skeletal muscle. Methods Enzymol. 1988;157:12\u201326.","journal-title":"Methods Enzymol"},{"key":"1347_CR11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1152\/ajpcell.1989.256.2.C358","volume":"256","author":"T Ohta","year":"1989","unstructured":"Ohta T, Endo M, Nakano T, Morohoshi Y, Wanikawa K, Ohga A. Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle. Am J Physiol. 1989;256:358\u201367.","journal-title":"Am J Physiol"},{"key":"1347_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s005400050002","volume":"14","author":"S Oku","year":"2000","unstructured":"Oku S, Mukaida K, Nosaka S, Sai Y, Maehara Y, Yuge O. Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility. J Anesth. 2000;14:6\u201313.","journal-title":"J Anesth"},{"key":"1347_CR13","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","volume":"104","author":"MCA Ibarra","year":"2006","unstructured":"Ibarra MCA, Wu S, Murayama K, Minami M, Ichihara Y, Kikuchi H, et al. Malignant hyperthermia in Japan. Anesthesiology. 2006;104:1146\u201356.","journal-title":"Anesthesiology"},{"key":"1347_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00540-006-0495-5","volume":"21","author":"T Migita","year":"2007","unstructured":"Migita T, Mukaida K, Kawamoto M, Kobayashi M, Yuge O. Fulminant-type malignant hyperthermia in Japan: cumulative analysis of 383 cases. J Anesth. 2007;21:285\u20138.","journal-title":"J Anesth"},{"key":"1347_CR15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0310057X0903700313","volume":"37","author":"T Migita","year":"2009","unstructured":"Migita T, Mukaida K, Hamada H, Kobayashi M, Nishino I, Yuge O, Kawamoto M. Effects of propofol on calcium homeostasis in human skeletal muscle. Anaesth Intensive Care. 2009;37:415\u201325.","journal-title":"Anaesth Intensive Care"},{"key":"1347_CR16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1023\/A:1018671520294","volume":"18","author":"JL Liberona","year":"1997","unstructured":"Liberona JL, Caviedes P, Tascon S, Hidalgo J, Giglio JR, Sampaio SV, Caviedes R, Jaimovich E. Expression of ion channels during differentiation of a human skeletal muscle cell line. J Muscle Res Cell Motil. 1997;18:587\u201398.","journal-title":"J Muscle Res Cell Motil"},{"key":"1347_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1113\/jphysiol.2003.051730","volume":"555","author":"R Squecco","year":"2004","unstructured":"Squecco R, Bencini C, Piperio C, Francini F. L-type Ca2+ channel and ryanodine receptor cross-talk in frog skeletal muscle. J Physiol. 2004;555:137\u201352.","journal-title":"J Physiol"},{"key":"1347_CR18","doi-asserted-by":"crossref","first-page":"37471","DOI":"10.1074\/jbc.M701379200","volume":"282","author":"T Yang","year":"2007","unstructured":"Yang T, Allen PD, Pessah IN, Lopez JR. Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J Biol Chem. 2007;282:37471\u20138.","journal-title":"J Biol Chem"},{"key":"1347_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.ne.17.030194.002151","volume":"17","author":"F Hofmann","year":"1994","unstructured":"Hofmann F, Biel M, Flockerzi V. Molecular basis for Ca2+ channel diversity. Annu Rev Neurosci. 1994;17:399\u2013418.","journal-title":"Annu Rev Neurosci"},{"key":"1347_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/eurheartj\/18.suppl_A.71","volume":"18","author":"LH Opie","year":"1997","unstructured":"Opie LH. Pharmacological differences between calcium antagonists. Eur Heart J. 1997;18:71\u20139.","journal-title":"Eur Heart J"},{"key":"1347_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","volume":"37","author":"GH Hockerman","year":"1997","unstructured":"Hockerman GH, Peterson BZ, Johnson BD, Catterall WA. Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Texicol. 1997;37:361\u201396.","journal-title":"Annu Rev Pharmacol Texicol"},{"key":"1347_CR22","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M007165200","volume":"275","author":"S Yamaguchi","year":"2000","unstructured":"Yamaguchi S, Okamura Y, Nagao T, Adachi-Akahane S. Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists. J Biol Chem. 2000;275:41504\u201311.","journal-title":"J Biol Chem"},{"key":"1347_CR23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/bja\/aeg118","volume":"90","author":"K Hirota","year":"2003","unstructured":"Hirota K, Hashiba E, Yoshioka H, Kabara S, Matsuki A. Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation. Br J Anaesth. 2003;90:671\u20135.","journal-title":"Br J Anaesth"},{"key":"1347_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0165-6147(98)01171-7","volume":"19","author":"J Striessnig","year":"1998","unstructured":"Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci. 1998;19:108\u201315.","journal-title":"Trends Pharmacol Sci"},{"key":"1347_CR25","doi-asserted-by":"crossref","unstructured":"Weigl LG, Hohenegger M, Kress HG. J. Dihydropyridine-induced Ca2+ release from ryanodine-sensitive Ca2+ pools in human skeletal muscle cells. Physiol. 2000;525 2:461\u20139.","DOI":"10.1111\/j.1469-7793.2000.t01-1-00461.x"},{"key":"1347_CR26","first-page":"124","volume":"26","author":"T Migita","year":"2009","unstructured":"Migita T, Mukaida K, Hamada H, Kawamoto M. Do Ca2+ channel blockers improve malignant hyperthermia crisis? Eur J Anaesth. 2009;26:124.","journal-title":"Eur J Anaesth"},{"key":"1347_CR27","doi-asserted-by":"crossref","unstructured":"Paul-Pletzer K, Yamamoto T, Bhat MB, MA J, Ikemoto N, Jimenez LS, Morimoto H, Williams PG, Parness J. Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem. 2002;277:34918\u201323.","DOI":"10.1074\/jbc.M205487200"},{"key":"1347_CR28","doi-asserted-by":"crossref","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","volume":"272","author":"BR Fruen","year":"1997","unstructured":"Fruen BR, Mickelson JR, Louis CF. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem. 1997;272:26965\u201371.","journal-title":"J Biol Chem"},{"key":"1347_CR29","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1124\/mol.107.043299","volume":"73","author":"G Cherednichenko","year":"2008","unstructured":"Cherednichenko G, Ward CW, Feng W, Cabrales E, Michaelson L, Samso M, Lopez JR, Allen PD, Pessah IN. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol Pharmacol. 2008;73:1203\u201312.","journal-title":"Mol Pharmacol"},{"issue":"44","key":"1347_CR30","doi-asserted-by":"crossref","first-page":"15793","DOI":"10.1073\/pnas.0403485101","volume":"101","author":"G Cherednichenko","year":"2004","unstructured":"Cherednichenko G, Hurne AM, Fessenden JD, Lee EH, Allen PD, Beam KG, Pessah IN. Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc Natl Acad Sci USA. 2004;101(44):15793\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1347_CR31","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1113\/jphysiol.2009.172148","volume":"587","author":"RT Dirksen","year":"2009","unstructured":"Dirksen RT. Checking your DOCCs and feet: molecular mechanisms of Ca2+ entry in skeletal muscle. J Physiol. 2009;587:3139\u201347.","journal-title":"J Physiol"},{"key":"1347_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1085\/jgp.200810105","volume":"133","author":"RA Bannister","year":"2009","unstructured":"Bannister RA, Pessah IN, Beam KG. The skeletal L-type Ca2+ current is a major contributor to excitation-coupled Ca2+ entry. J Gen Physiol. 2009;133:79\u201391.","journal-title":"J Gen Physiol"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-012-1347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-012-1347-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-012-1347-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T18:59:14Z","timestamp":1561316354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-012-1347-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1007\/s00540-012-1347-0","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}